Company Name, Ticker, Competitors, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
ADAP's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Adaptimmune Therapeutics Plc News
Adaptimmune Therapeutics Plc's Revenue per Employee
Adaptimmune Therapeutics Plc's ROI
Adaptimmune Therapeutics Plc Business Description
Adaptimmune Therapeutics Plc Executive Officers
Economic Indicators
Fundamentals
Adaptimmune Therapeutics Plc Growth Rates
Adaptimmune Therapeutics Plc Profitability
Adaptimmune Therapeutics Plc Valuation
Adaptimmune Therapeutics Plc Management Effectiveness
Adaptimmune Therapeutics Plc Financial Strength
Adaptimmune Therapeutics Plc Efficiency
Adaptimmune Therapeutics Plc Dividend
Financials
Adaptimmune Therapeutics Plc Business Segments
Adaptimmune Therapeutics Plc Income Statement
Adaptimmune Therapeutics Plc Balance Sheets
Adaptimmune Therapeutics Plc Cash Flow Statement
Adaptimmune Therapeutics Plc Geographic Information
Suppliers
Adaptimmune Therapeutics Plc Suppliers Performance
ADAP Suppliers Stock Performance
ADAP Suppliers Growth Rates
ADAP Suppliers Data
ADAP Suppliers Efficiency
ADAP Suppliers Management Effectiveness
ADAP Suppliers Valuation
ADAP Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Adaptimmune Therapeutics Plc Market Share
Adaptimmune Therapeutics Plc Competition Performance
Adaptimmune Therapeutics Plc Competitors Results
ADAP Competitors Stock Performance
ADAP Competitors Growth Rates
ADAP Workforce Efficiency at the Competitors
ADAP Competitors Efficiency
ADAP Competitors Management Effectiveness
ADAP Competitors Valuation
Customers & Markets
Adaptimmune Therapeutics Plc Customers Demand
ADAP Customers Expenditure Growth Rates
ADAP Customers Performance
ADAP Customers Stock Performance
ADAP Customers Growth Rates
ADAP Workforce Efficiency at the Customers
ADAP Customers Efficiency
ADAP Customers Management Effectiveness
ADAP Customers Valuation
ADAP Customers by Companys' Segments
Charts & Quotes
Adaptimmune Therapeutics Plc Comparison Charts
ADAP OHLC Charts
ADAP's Tehnical Upper Indicators
ADAP's Tehnical Lower Indicators
ADAP's Weekly Charts
ADAP's Monthly Charts
Adaptimmune Therapeutics Plc's Profile
Company Charts and Quotes
Adaptimmune Therapeutics Plc News
Adaptimmune Therapeutics Plc's Geographic Information
Adaptimmune Therapeutics Plc's Income Statement
Adaptimmune Therapeutics Plc's Balance Sheets
Adaptimmune Therapeutics Plc's Cash Flow Statement
Adaptimmune Therapeutics Plc's Profitability
Adaptimmune Therapeutics Plc's Financials
Adaptimmune Therapeutics Plc's Growth Rates
Adaptimmune Therapeutics Plc's Suppliers
Adaptimmune Therapeutics Plc's Competitors
Adaptimmune Therapeutics Plc's Markets & Customers
Adaptimmune Therapeutics Plc's Market Share
ADAP's Suppliers Valuation
ADAP's Competitors Management Effectiveness
ADAP's Charts Money Flow Index
ADAP's Customers Demand
Economic Indicators
Capital Expenditures Growth by Industry
Efficiency Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Construction Spending
News
Economy News
Stock News
Technical Analysis
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Cash Flow Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Adaptimmune Therapeutics Plc
(
ADAP
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Biotechnology & Pharmaceuticals
Industry
•
Biotechnology & Pharmaceuticals
Sector
•
Healthcare
Adaptimmune Therapeutics Plc's Yearly Net Cash Flow Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Net Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Net Cash Flow Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
ADAP Annual Net Cash Flow Growth
2023
2022
2021
2020
2019
Y / Y Annual Net Cash Flow Change
-
-
1271.38 %
-
-
Annual Net Cash Flow (in millions $)
$37.42
$-42.06
$90.18
$6.58
$-17.57
ADAP Company Profile
>>
Back to ADAP Fundamentals at a Glance
>>
Back to ADAP Growth Comparisons
Annual Net Cash Flow Growth Comment
In the fiscal year ended 2023, company achieved Annual Net Cash Flow of $37.42 millions compare to net cash outflow of $-42.06 millions realized a year before.
Adaptimmune Therapeutics Plc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2023 Annual Net Cash Flow within Healthcare Sector
Y/Y Net Cash Flow Growth %
2023 Annual Net Cash Flow
Vertex Pharmaceuticals Inc